ELITE PHARMACEUTICALS INC /NV/ Quarterly Return On Assets in % from Q4 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Return On Assets history and growth rate from Q4 2011 to Q3 2024.
  • Elite Pharmaceuticals Inc /Nv/ Return On Assets for the quarter ending September 30, 2024 was -7.64 %, a 123% decline year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ annual Return On Assets for 2023 was 41.9 %, a 275% increase from 2022.
  • Elite Pharmaceuticals Inc /Nv/ annual Return On Assets for 2022 was 11.2 %, a 65.4% decline from 2021.
  • Elite Pharmaceuticals Inc /Nv/ annual Return On Assets for 2021 was 32.3 %, a 53.6% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -7.64 -41.5 -123% Jul 1, 2024 Sep 30, 2024
Q2 2024 24.7 +15.5 +168% Apr 1, 2024 Jun 30, 2024
Q1 2024 29.2 +21.8 +293% Jan 1, 2024 Mar 31, 2024
Q4 2023 26.7 +11.2 +72.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 33.8 +18 +114% Jul 1, 2023 Sep 30, 2023
Q2 2023 9.24 -9.46 -50.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 7.42 -20.5 -73.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 15.5 -4.67 -23.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 15.8 -4.01 -20.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 18.7 -4.07 -17.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 27.9 +9.41 +51% Jan 1, 2022 Mar 31, 2022
Q4 2021 20.2 -3.7 -15.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 19.8 +9.71 +96.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 22.8 +28.5 Apr 1, 2021 Jun 30, 2021
Q1 2021 18.5 +27.7 Jan 1, 2021 Mar 31, 2021
Q4 2020 23.9 +48.1 Oct 1, 2020 Dec 31, 2020
Q3 2020 10.1 +35.7 Jul 1, 2020 Sep 30, 2020
Q2 2020 -5.75 +22.8 +79.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -9.25 +25.6 +73.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 -24.3 +9.15 +27.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 -25.7 -0.09 -0.35% Jul 1, 2019 Sep 30, 2019
Q2 2019 -28.6 -18.2 -176% Apr 1, 2019 Jun 30, 2019
Q1 2019 -34.8 -23.4 -205% Jan 1, 2019 Mar 31, 2019
Q4 2018 -33.4 -21.2 -174% Oct 1, 2018 Dec 31, 2018
Q3 2018 -25.6 -20.1 -365% Jul 1, 2018 Sep 30, 2018
Q2 2018 -10.3 -11.9 -754% Apr 1, 2018 Jun 30, 2018
Q1 2018 -11.4 -22.4 -203% Jan 1, 2018 Mar 31, 2018
Q4 2017 -12.2 -57.9 -127% Oct 1, 2017 Dec 31, 2017
Q3 2017 -5.49 -10.6 -209% Jul 1, 2017 Sep 30, 2017
Q2 2017 1.58 +15.9 Apr 1, 2017 Jun 30, 2017
Q1 2017 11 +13.4 Jan 1, 2017 Mar 31, 2017
Q4 2016 45.7 +101 Oct 1, 2016 Dec 31, 2016
Q3 2016 5.06 -9.88 -66.1% Jul 1, 2016 Sep 30, 2016
Q2 2016 -14.3 -60 -131% Apr 1, 2016 Jun 30, 2016
Q1 2016 -2.33 -23.3 -111% Jan 1, 2016 Mar 31, 2016
Q4 2015 -55.6 +252 +81.9% Oct 1, 2015 Dec 31, 2015
Q3 2015 14.9 +385 Jul 1, 2015 Sep 30, 2015
Q2 2015 45.7 +520 Apr 1, 2015 Jun 30, 2015
Q1 2015 21 +570 Jan 1, 2015 Mar 31, 2015
Q4 2014 -307 -250 -437% Oct 1, 2014 Dec 31, 2014
Q3 2014 -370 -388 -2133% Jul 1, 2014 Sep 30, 2014
Q2 2014 -474 -598 -485% Apr 1, 2014 Jun 30, 2014
Q1 2014 -549 -563 -3950% Jan 1, 2014 Mar 31, 2014
Q4 2013 -57.2 +12.3 +17.7% Oct 1, 2013 Dec 31, 2013
Q3 2013 18.2 +93.6 Jul 1, 2013 Sep 30, 2013
Q2 2013 123 +73.8 +149% Apr 1, 2013 Jun 30, 2013
Q1 2013 14.3 +154 Jan 1, 2013 Mar 31, 2013
Q4 2012 -69.5 +152 +68.7% Oct 1, 2012 Dec 31, 2012
Q3 2012 -75.4 Jul 1, 2012 Sep 30, 2012
Q2 2012 49.5 Apr 1, 2012 Jun 30, 2012
Q1 2012 -140 Jan 1, 2012 Mar 31, 2012
Q4 2011 -222 Oct 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.